HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CGP 64213

structure in first source

Also Known As:

CGP-64213; CGP64213

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Bédard, Paul J: 1 article (03/2003)
2.	Calon, Frédéric: 1 article (03/2003)
3.	Di Paolo, Thérèse: 1 article (03/2003)
4.	Hornykiewicz, Oleh: 1 article (03/2003)
5.	Morissette, Marc: 1 article (03/2003)
6.	Rajput, Ali H: 1 article (03/2003)

Related Diseases

1.

Parkinson Disease (Parkinson's Disease)

03/01/2003 - "Striatal (35)S-labeled t-butylbicyclophosphorothionate ([(35)S]TBPS) and [(3)H]flunitrazepam binding to GABA(A) receptors were unchanged in patients with Parkinson's disease, whereas [(125)I]CGP 64213 -specific binding to GABA(B) receptors was decreased in the putamen and external segment of the globus pallidus of parkinsonian patients compared with controls. "

Related Drugs and Biologics

1.	GABA-B Receptors
2.	GABA-A Receptors (GABA(A) Receptor)
3.	Flunitrazepam (Rohypnol)
4.	tert-butylbicyclophosphorothionate